BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 9699705)

  • 1. Novel antipsychotics and the neuroleptic malignant syndrome: a review and critique.
    Hasan S; Buckley P
    Am J Psychiatry; 1998 Aug; 155(8):1113-6. PubMed ID: 9699705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].
    Khaldi S; Kornreich C; Choubani Z; Gourevitch R
    Encephale; 2008 Dec; 34(6):618-24. PubMed ID: 19081460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroleptic malignant syndrome associated with atypical antipsychotics in pediatric patients: a review of published cases.
    Croarkin PE; Emslie GJ; Mayes TL
    J Clin Psychiatry; 2008 Jul; 69(7):1157-65. PubMed ID: 18572981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fever, confusion, acute kidney injury: is this atypical neuroleptic malignant syndrome following polypharmacy with clozapine and risperidone?
    Cherry S; Siskind D; Spivak V; Wysoczanski D; Halangoda P
    Australas Psychiatry; 2016 Dec; 24(6):602-603. PubMed ID: 27194777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clozapine-associated neuroleptic malignant syndrome: two new cases and a review of the literature.
    Karagianis JL; Phillips LC; Hogan KP; LeDrew KK
    Ann Pharmacother; 1999 May; 33(5):623-30. PubMed ID: 10369628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical neuroleptic malignant syndrome associated with risperidone treatment.
    Newman M; Adityanjee ; Jampala C
    Am J Psychiatry; 1997 Oct; 154(10):1475. PubMed ID: 9326841
    [No Abstract]   [Full Text] [Related]  

  • 7. Extreme elevation of creatinine phosphokinase levels in neuroleptic malignant syndrome associated with atypical antipsychotics.
    Ladds B; Thomas P; Mejia C; Hauser D
    Am J Psychiatry; 2009 Jan; 166(1):114-5. PubMed ID: 19122020
    [No Abstract]   [Full Text] [Related]  

  • 8. Neuroleptic malignant syndrome associated with risperidone in a male with early-onset schizophrenia.
    Mané A; Baeza I; Morer A; Lázaro ML; Bernardo M
    J Child Adolesc Psychopharmacol; 2005 Dec; 15(6):844-5. PubMed ID: 16379503
    [No Abstract]   [Full Text] [Related]  

  • 9. A case of neuroleptic malignant syndrome with clozapine and risperidone.
    Beauchemin MA; Millaud F; Nguyen KA
    Can J Psychiatry; 2002 Nov; 47(9):886. PubMed ID: 12500761
    [No Abstract]   [Full Text] [Related]  

  • 10. Neuroleptic malignant syndrome due to atypical neuroleptics: three episodes in one patient.
    Bottlender R; Jäger M; Hofschuster E; Dobmeier P; Möller HJ
    Pharmacopsychiatry; 2002 May; 35(3):119-21. PubMed ID: 12107858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clozapine-associated neuroleptic malignant syndrome followed by catatonia: a case report].
    Erol A; Putgül G; Sert E; Mete L
    Turk Psikiyatri Derg; 2013; 24(2):140-4. PubMed ID: 23754268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case study. Risperidone-Induced neuroleptic malignant syndrome in an adolescent.
    Robb AS; Chang W; Lee HK; Cook MS
    J Child Adolesc Psychopharmacol; 2000; 10(4):327-30. PubMed ID: 11191694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caution is still needed when prescribing atypical antipsychotics.
    Carey S
    Br J Hosp Med (Lond); 2008 May; 69(5):299. PubMed ID: 18557562
    [No Abstract]   [Full Text] [Related]  

  • 14. Neuroleptic malignant syndrome and risperidone: a case report.
    Bonwick RJ; Hopwood MJ; Morris PL
    Aust N Z J Psychiatry; 1996 Jun; 30(3):419-21. PubMed ID: 8839956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of clozapine-induced neuroleptic malignant syndrome.
    Miller DD; Sharafuddin MJ; Kathol RG
    J Clin Psychiatry; 1991 Mar; 52(3):99-101. PubMed ID: 1672311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxic interaction between risperidone and clozapine: a case report.
    Kontaxakis VP; Havaki-Kontaxaki BJ; Stamouli SS; Christodoulou GN
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Feb; 26(2):407-9. PubMed ID: 11817521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of CYP2D6 and TaqI A polymorphisms in malignant neuroleptic syndrome: two case reports with three episodes.
    Zivković M; Mihaljević-Peles A; Sagud M; Silić A; Mihanović M
    Psychiatr Danub; 2010 Mar; 22(1):112-6. PubMed ID: 20305604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical neuroleptic malignant syndrome associated with risperidone treatment in two adolescents.
    Zalsman G; Lewis R; Konas S; Loebstein O; Goldberg P; Burguillo F; Nahshoni E; Munitz H
    Int J Adolesc Med Health; 2004; 16(2):179-82. PubMed ID: 15266995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical neuroleptic malignant syndrome in patients treated with aripiprazole and clozapine: a case-series study and short review.
    Tseng PT; Chang YC; Chang CH; Wang HY; Cheng YS; Wu CK; Chen YW; Chung W
    Int J Psychiatry Med; 2015; 49(1):35-43. PubMed ID: 25838319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clozapine-induced neuroleptic malignant syndrome in an adolescent.
    Matheson KM; Gray G
    J Child Adolesc Psychopharmacol; 2012 Aug; 22(4):322-4. PubMed ID: 22897669
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 22.